Shantha Biotechnics
Hyderabad
About Shantha Biotechnics
Shantha develops, manufactures, and markets several vaccines and operates at international standards in a state-of-the-art facility. Shantha was created in 1993 by Dr. Varaprasad Reddy and is based in Hyderabad, India. Shantha works with supranational organizations like UNICEF and PAHO to supply major international markets including Asia-Pacific, Africa, and Latin America. In 1997, Shantha launched SHANVAC-B™, the first recombinant Hepatitis B vaccine produced in India. SHANVAC-B™, SHANTETRA™ (combination vaccine of Diphtheria, Pertussis, Tetanus and Hepatitis B), SHAN5™ (combination vaccine of Diphtheria, Pertussis, Tetanus, Haemophilus influenza B, and Hepatitis B) and SHANTT™ (Tetanus toxoid vaccine) are prequalified by the World Health Organization for supplying to United Nations agencies globally. Shantha also has an important portfolio of vaccines in development.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Website: shanthabiotech.com
- Phone: 91 40 6630 1000
Industries & Categories
Biotechnology, Health Care, Manufacturing
Canonical: https://fsome.com/organization/shantha-biotechnics-2916232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.